FDA approves first new treatment for lupus in five decades Los Angeles Times Benlysta, developed by Human Genome Sciences, offers possible relief to symptoms such as joint pain, fatigue, fever and rashes, and could allow patients to use less prednisone. By Andrew Zajac The Food and Drug Administration on Wednesday approved ... |
No comments:
Post a Comment